Certara, Inc. (NASDAQ:CERT) Insider Sells $796,517.65 in Stock

Certara, Inc. (NASDAQ:CERTGet Rating) insider Leif E. Pedersen sold 51,223 shares of the business’s stock in a transaction on Tuesday, November 22nd. The shares were sold at an average price of $15.55, for a total transaction of $796,517.65. Following the transaction, the insider now owns 175,500 shares of the company’s stock, valued at $2,729,025. The transaction was disclosed in a legal filing with the SEC, which is available through this link.

Certara Stock Performance

Certara stock opened at $16.49 on Thursday. The company has a quick ratio of 3.99, a current ratio of 3.99 and a debt-to-equity ratio of 0.28. The company has a market capitalization of $2.63 billion, a PE ratio of -549.67, a P/E/G ratio of 1.10 and a beta of 1.09. The firm has a fifty day simple moving average of $13.19 and a two-hundred day simple moving average of $17.29. Certara, Inc. has a twelve month low of $10.60 and a twelve month high of $29.99.

Analyst Upgrades and Downgrades

A number of research firms have recently commented on CERT. Morgan Stanley reduced their price target on shares of Certara from $24.00 to $20.00 and set an “equal weight” rating for the company in a research report on Wednesday, August 24th. Credit Suisse Group cut their target price on shares of Certara from $22.00 to $20.00 and set an “outperform” rating for the company in a research report on Monday, November 14th. Barclays cut their target price on shares of Certara from $21.00 to $17.00 and set an “overweight” rating for the company in a research report on Thursday, October 6th. SVB Leerink cut their target price on shares of Certara from $29.00 to $26.00 and set an “outperform” rating for the company in a research report on Wednesday, August 10th. Finally, Piper Sandler cut their target price on shares of Certara from $28.00 to $25.00 and set an “overweight” rating for the company in a research report on Wednesday, August 10th. One analyst has rated the stock with a hold rating and six have given a buy rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $23.14.

Hedge Funds Weigh In On Certara

Several hedge funds and other institutional investors have recently modified their holdings of the company. SG Americas Securities LLC raised its stake in shares of Certara by 3.7% during the second quarter. SG Americas Securities LLC now owns 13,955 shares of the company’s stock valued at $299,000 after acquiring an additional 492 shares during the last quarter. Edmond DE Rothschild Holding S.A. raised its stake in shares of Certara by 1.2% during the second quarter. Edmond DE Rothschild Holding S.A. now owns 65,819 shares of the company’s stock valued at $1,412,000 after acquiring an additional 811 shares during the last quarter. MML Investors Services LLC raised its stake in shares of Certara by 6.2% during the third quarter. MML Investors Services LLC now owns 14,443 shares of the company’s stock valued at $192,000 after acquiring an additional 840 shares during the last quarter. PNC Financial Services Group Inc. raised its stake in shares of Certara by 18.3% during the first quarter. PNC Financial Services Group Inc. now owns 5,841 shares of the company’s stock valued at $126,000 after acquiring an additional 905 shares during the last quarter. Finally, Summit Creek Advisors LLC raised its stake in shares of Certara by 0.4% during the first quarter. Summit Creek Advisors LLC now owns 242,239 shares of the company’s stock valued at $5,203,000 after acquiring an additional 910 shares during the last quarter. 77.42% of the stock is owned by institutional investors.

Certara Company Profile

(Get Rating)

Certara, Inc provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access. It offers medicines to patients using biosimulation software, technology, and services to transform drug discovery and development.

Recommended Stories

Insider Buying and Selling by Quarter for Certara (NASDAQ:CERT)

Receive News & Ratings for Certara Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Certara and related companies with MarketBeat.com's FREE daily email newsletter.